Document Detail


Eplerenone improves vascular function and reduces platelet activation in diabetic rats.
MedLine Citation:
PMID:  20228414     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Diabetes is associated with endothelial dysfunction and platelet activation, both of which contribute to increased cardiovascular risk. We investigated whether the selective mineralocorticoid receptor (MR) antagonist eplerenone improves endothelial dysfunction and reduces platelet activation in diabetic rats. Male Wistar-rats were injected with streptozotocin (50 mg/kg i.v.) to induce insulin-deficient diabetes. After 2 weeks, treatment with eplerenone (100 mg/kg/day) or vehicle was initiated for 2 weeks. Aortic superoxide production determined by lucigenin-enhanced chemiluminescence and 2-hydroxyethidium formation was significantly increased in rats with diabetes and reduced by treatment with eplerenone (chemiluminescence: control 2045+/-227, STZ-placebo 3977+/-340, p<0.05 vs. control, STZ-eplerenone 1762+/-307, p<0.05 vs. STZ-placebo). Endothelium-dependent vasorelaxation was significantly attenuated in diabetic rats and was normalized by eplerenone (maximum relaxation in % of precontraction: control 95+/-3, STZ-placebo 82+/-3, p<0.01 vs. control, STZ-eplerenone 99+/-1, p<0.01 vs. STZ-placebo). Treatment with the selective MR antagonist significantly reduced fibrinogen-binding on activated GPIIb/IIIa (immunofluorescence: control 161+/-7, STZ-placebo 208+/-16, p<0.05 vs. control, STZ-eplerenone 173+/-6, p<0.05 vs. STZ-placebo). Eplerenone improves endothelial function by reducing superoxide formation and increasing NO bioavailability in diabetic rats. Platelet activation was significantly reduced by eplerenone. Selective MR blockade may constitute a useful therapeutic approach for treatment of vascular dysfunction in diabetes.
Authors:
A Schafer; C Vogt; D Fraccarollo; J Widder; U Flierl; S K Hildemann; G Ertl; J Bauersachs
Related Documents :
8352444 - Effect of high fat feeding on glucose tolerance in neonatally streptozotocin-treated ra...
9121164 - A purified extract from prickly pear cactus (opuntia fuliginosa) controls experimentall...
14703974 - Erythrocyte redox status in streptozotocin diabetic rats: effect of casearia esculenta ...
20213314 - Amelioration of streptozotocin-induced diabetes by agrocybe chaxingu polysaccharide.
20391204 - Physical activity and diabetes: an application of the theory of planned behaviour to ex...
8510524 - Carbohydrate fermentation decreases hepatic glucose output in healthy subjects.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society     Volume:  61     ISSN:  1899-1505     ISO Abbreviation:  J. Physiol. Pharmacol.     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-03-15     Completed Date:  2010-10-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9114501     Medline TA:  J Physiol Pharmacol     Country:  Poland    
Other Details:
Languages:  eng     Pagination:  45-52     Citation Subset:  IM    
Affiliation:
Medizinische Klinik und Poliklinik I, Universitatsklinikum Wurzburg, Julius-Maximilians-Universitat Wurzburg, Wurzburg, Germany. a.schaefer@medizin.uni-wuerzburg.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Diabetes Mellitus, Experimental / drug therapy*,  physiopathology
Dose-Response Relationship, Drug
Endothelium, Vascular / drug effects,  physiology*
Male
Platelet Aggregation Inhibitors / pharmacology,  therapeutic use*
Rats
Rats, Wistar
Spironolactone / analogs & derivatives*,  pharmacology,  therapeutic use
Vasodilation / drug effects,  physiology
Chemical
Reg. No./Substance:
0/Platelet Aggregation Inhibitors; 0/eplerenone; 52-01-7/Spironolactone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Involvement of the histaminergic system in cytidine 5'-diphosphocholine-induced reversal of critical...
Next Document:  Pharmacological inhibition of leukotriene biosynthesis: effects on the heart conductance.